Management of an acute multiple sclerosis flare versus chronic disease-modifying therapy is: Flare treated with and chronic with?

Prepare for the NBME Form 10 Step 2 Test. Utilize flashcards and multiple choice questions, with hints and explanations for each. Ace your exam preparation!

Multiple Choice

Management of an acute multiple sclerosis flare versus chronic disease-modifying therapy is: Flare treated with and chronic with?

Explanation:
In an acute MS flare you want to dampen the recent inflammatory attack quickly, while for chronic management you aim to reduce future attacks and slow disability progression. High-dose glucocorticoids are used to treat a flare because they rapidly suppress CNS inflammation and hasten recovery. If the relapse is severe or steroids don’t work, plasmapheresis can be considered, but it’s not the first-line choice for an acute attack. For chronic disease-modifying therapy, an immune-modulating agent like interferon beta is used to reduce relapse frequency and lesion formation over time. Other options exist, but interferon beta is a classic example of chronic MS therapy. Therefore, the best pairing is flare management with glucocorticoids and chronic disease modification with interferon beta.

In an acute MS flare you want to dampen the recent inflammatory attack quickly, while for chronic management you aim to reduce future attacks and slow disability progression. High-dose glucocorticoids are used to treat a flare because they rapidly suppress CNS inflammation and hasten recovery. If the relapse is severe or steroids don’t work, plasmapheresis can be considered, but it’s not the first-line choice for an acute attack. For chronic disease-modifying therapy, an immune-modulating agent like interferon beta is used to reduce relapse frequency and lesion formation over time. Other options exist, but interferon beta is a classic example of chronic MS therapy. Therefore, the best pairing is flare management with glucocorticoids and chronic disease modification with interferon beta.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy